Jivan Biologics - CA Marin, Larkspur 94939

Jivan Biologics entered the industry of Commercial Biotechnical Research in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Jerry Karabelas by calling (318) 382-0049 during business hours. You can also write to the business’ Single Location at 700 Larkspur Landing Circle, Larkspur, California CA 94939. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Jivan Biologics
Representative: Jerry Karabelas
Place of Business: 700 Larkspur Landing Circle, Larkspur, CA 94939
Contact Number: (318) 382-0049
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2001
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Jivan Biologics is a company operating from Marin, California providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2001 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Jivan Biologics has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Jerry Karabelas at (318) 382-0049 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 700 Larkspur Landing Circle in Larkspur, California 94939 and can be engaged online through the company website at , the company Twitter , and Facebook page .